Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT138902283950N1
IRCT138902283950N1
Completed
未知

Gonadotropin-releasing hormone antagonist vs agonist in Iranian normo-responders undergoing in vitro fertilisation: A Randomized Clinical Trial

Tehran Univercity of Medical Sciences0 sites300 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsresponse to controlled ovarian stimulation.In vitro fertilization

Overview

Phase
未知
Intervention
Not specified
Conditions
response to controlled ovarian stimulation.
Sponsor
Tehran Univercity of Medical Sciences
Enrollment
300
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Tehran Univercity of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •age \<38 years; normal basal serum FSH; 20 \= BMI \<30 kg/m2; regular menstrual cycle. Exclusion criteria: Polycystic ovary syndrome; severe endometriosis; history of poor response in previous treatment cycles; history of repeated IVF failure more than 3 cycles failed.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
GNRH agonist vs GNRH antagonist in infertility treatment.Infertility in endometriosis.Endometriosis
IRCT20230403057803N1Shahid Beheshti University of Medical Sciences120
Recruiting
Not Applicable
Gonadotropin-releasing hormone (GnRH) agonist for prevention of chemotherapy induced menopause in malignant ovarian germ cell tumor: a multicenter studyDiseases of The genitoruinary system
KCT0003286Bundang CHA General Hospital65
Recruiting
Phase 2
Women undergoing chemotherapy plus gonadotrophin-releasing hormone (GnRH) analouges compared with control to protect ovairan functioWomen of reproductive age receiving chemotherapyCancerReproductive Health and Childbirth - Fertility including in vitro fertilisationCancer - Breast
ACTRN12609001059257Ass. Prof. Dr. Eman Elgindy100
Completed
Phase 4
Ganirelix in insemination cycles of women with premature luteinizatioinfertilityintrauterine inseminationReproductive Health and Childbirth - Fertility including in vitro fertilisation
ACTRN12612000153819Mersin University114
Completed
Phase 2
Effect of Gonadotropin-releasing hormone analogue( GnRh-a ) for in vitro fertillization cycles (IVF)
IRCT20160722029027N7Shahid Beheshti University of Medical Sciences72